News

Dr. Cherkasov
Posted: 2017-10-13

Federal Minister of Justice and Attorney General of Canada Jody Wilson-Raybould today announced UBC's successful CFI Infrastructure Fund awardees. The largest grant, $9 million, was awarded to a research program led by Dr. Artem Cherkasov, titled Accelerated Drug Discovery Using Clinical Translation (ADDUCT).

Posted: 2017-10-06

In the last week, two VPC researchers have been awarded grants to fund research projects aimed at improving the treatment prostate cancer.

Posted: 2017-09-13

Thee publications out of the VPC describing work towards the development of new therapeutics were published in the last week.

Posted: 2017-08-23

The results of research awards from two agencies today demonstrate the VPC's successful translation of basic research into discoveries that are moving to clinical applications.

Posted: 2017-07-26

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.

Posted: 2017-07-19

The Best of the AACR Journals collection 2016 highlights the most-cited articles published in 2015 across the AACR journals.

Posted: 2017-07-18

On Saturday September 23, 2017 the University of British Columbia and the Vancouver Prostate Centre’s Prostate Cancer Supportive Care Program will be participating in the 17th Annual Pacific Northwest Prostate Cancer Symposium. Click here to see the agenda (PDF opens in new tab). In conjunction with the OHSU Knight Cancer Institute and the University of Washington School of Medicine, this live symposium is for patients, their families and health care professionals...

Posted: 2017-06-29

The Journal of the National Cancer Institute today published a landmark multi-institutional study describing the first comprehensive comparison of blood-based tumour biopsy versus metastatic tissue biopsy for lethal prostate cancer.

Posted: 2017-05-16

Congratulations to Drs. Collins, Daugaard & Wang on being awarded five-year grants in the CIHR Project Grant: Fall 2016 competition. Dr. Wang is also a co-investigator on a five-year grant awarded to Dr. He at University Health Network (Toronto). Congratulations also to Dr. William Morris of the BC Cancer Agency and his research team, including our Centre's Dr. Alan So, on being awarded a six-year grant in the same competition.

Posted: 2017-04-20

UBC Media release: April 20, 2017

A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.